Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Stem Cells and Cancer Stem Cells, Volume 10

Therapeutic Applications in Disease and Injury - Previously published in hardcover
BuchKartoniert, Paperback
298 Seiten
Englisch
Springer Netherlandserschienen am23.08.2016Softcover reprint of the original 1st ed. 2013
Mesenchymal Stem Cells section includes chapters on the use of stem cells in bone regeneration, studies and trials of stem cells in autoimmune diseases, and differences between adipose tissue-derived mesenchymal stem cells and bone marrow-derived mesenchymal stem cells as regulators of immune response.mehr
Verfügbare Formate
BuchKartoniert, Paperback
EUR160,49
BuchGebunden
EUR160,49

Produkt

KlappentextMesenchymal Stem Cells section includes chapters on the use of stem cells in bone regeneration, studies and trials of stem cells in autoimmune diseases, and differences between adipose tissue-derived mesenchymal stem cells and bone marrow-derived mesenchymal stem cells as regulators of immune response.
ZusammenfassungThis book surveys current understanding of the causes, diagnosis and cell-based treatment of major diseases and tissue and organ injuries, and reviews research on generation, preservation and uses of stem cells in fighting disease and regenerating tissue.
Details
ISBN/GTIN978-94-024-0718-1
ProduktartBuch
EinbandartKartoniert, Paperback
Erscheinungsjahr2016
Erscheinungsdatum23.08.2016
AuflageSoftcover reprint of the original 1st ed. 2013
ReiheStem Cells and Cancer Stem Cells
Seiten298 Seiten
SpracheEnglisch
Gewicht761 g
IllustrationenXLII, 298 p.
Artikel-Nr.43742161
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Prelims.- I Mesenchymal stem cells.- Mesenchymal stem cells in bone regeneration.- Experimental (preclinical) studies and clinical trials of adipose tissue-derived mesenchymal stem cells for Autoimmune diseases.- Validity of markers for epithelial cells and mesenchymal Cells.- Mesenchymal stem cell survival in infarcted myocardium: adhesion and anti-death signals.- Hepatogenic differentiation: comparison between adipose tissue -derived stem cells and bone marrow mesenchymal stem cells.- Fibrin for encapsulation of human mesenchymal stem cells for chondrogenic differentiation.- Differences between adipose tissue-derived mesenchymal  stem cells and bone marrow-derived mesenchymal stem cells as regulators of the immune response.- Transforming growth factor-beta induced chrondrogenic differentiation of bone marrow-derived mesenchymal stem cells: role of smad signaling pathways.- II Induced pluripotent stem cells.- Drug discovery using human ipsc based disease models and functional hepatic cells.- Generation of antigen-specific t lymphocytes from induced pluripotent stem cells for adoptive immunotherapy.- III Neural cells and neural stem cells.- Genetic identification of human embryonic stem cell-derived neural cell types using bacterial artificial chromosomes.- Moderate low temperature preserves the stemness of neural stem cells (methods).- IV Role of stem cells in disease.- High-dose chemotherapy with autologous stem cell support in the treatment of transformed b-cell non-hodgkin's lymphomas.- The wnt/β-catenin pathway as a potential target for drug Resistant leukemic stem cells.- Bone marrow stem cell therapies for diabetes mellitus and its complications.- Thyroid cancer stem cells - strategies for therapeutic targeting.- Role of cancer stem cell in mammary carcinogenesis and its clinical implication.- Critical analysis of parkinson´s disease models and cell-based therapy.- Presence of an early lineage stem cell phenotype in meningioma-initiatingcells.- Isolation and characterization of cancer stem cells from dog glioblastoma.- Role of stem cell niche in the development of bone metastases (an update).- Treatment of hemophilia a using b cell-directed protein delivery.-V Stem cell transplantation.- Reduction in the risk invasive fungal infection relapse in patients undergoing allogenic stem cell transplantation using caspofunginas secondary prophylaxis.- Hematopoietic stem cell transplantation in elderly patients with myelodisplastic syndrome and acute myelogenous leukemia: use of busulfan/fludarabine for conditioning.- Co-transplantation of islets with mesenychymal stem cells improves islet revascularization and reversal of hyperglycemia.- Significance of interleukin -7 receptor alpha polymorphisms in allogeneic stem cell transplantation.- Index.mehr